Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-979-5 | CAS number: 13078-36-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Using a read-across extrapolation approach from OECD 401 and 402 guideline limit studies on the structural analogue DTPA pentapotassium salt, DTPA trisodium salt is predicted to be of low acute oral and dermal toxicity with LD50 values in excess of 2,000 mg/kg.bw. The two substances are structurally similar and have the same metal ion, chelating mode of action.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 1984
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No data on batch number and composition; basic data given, comparable to guidelines (max reliability score can be 2)
- Justification for type of information:
- The source substance (DTPA 5K) and the target substance (DTPA 3Na) are the pentapotassium and trisodium salts of the same organic acid and are therefore structurally very similar. The purity/impurity profile for the source material is not characterised in the acute oral toxicity robust summary, but since the target material is > 99.9% pure and contains no detectable impurities, the extrapolation of acute oral toxicological properties from the source material to the target material is considered valid as a ‘worst case' scenario. The source material acute oral toxicity study was conducted according to OECD test guideline 401 and is considered reliable with restrictions (Category 2).
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Limit test was carried out at 5000 mg/kg bw instead of 2000 mg/kg bw.
- GLP compliance:
- yes
- Remarks:
- audited in-house
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: HC/CFY (Remote Sprague Dawley)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hacking and Churchill Ltd. Huntingdon, UK
- Age at study initiation: 4-6 weeks
- Weight at study initiation: 114-132 g
- Fasting period before study: overnight prior to exposure
- Housing: in groups by sex in metal cages with wire mesh floors
- Diet (e.g. ad libitum): ad lib
- Water (e.g. ad libitum): ad lib
- Acclimation period: for a minimum of 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 64 (mean)
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 3 To: 17 August 1984 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Test material applied as received.
DOSE VOLUME APPLIED: 3.76 ml/kg
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 2/sex in preliminary study
5/sex in main study - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 5 days (preliminary study), 14 days (main study)
- Frequency of observations and weighing: frequently on day of dosing, at least twice on following days. Weekly weighing.
- Necropsy of survivors performed: yes (main study) - Statistics:
- Not needed because of limit test
- Preliminary study:
- No mortality (0/4)
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- No mortality (0/10)
- Clinical signs:
- other: All animals (10/10): piloerection, hunched posture, abnormal gait, lethargy, decreased respiration rate, pallor of extremities, increased salivation, diarrhoea. Recovery was complete on day 5.
- Gross pathology:
- Terminal autopsy findings were normal.
- Other findings:
- None.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test material is not toxic as the acute lethal dose was > 5000 mg/kg bw
- Executive summary:
The study was performed to assess the acute toxicity of the test material following a single oral administration to the Sprague-Dawley strain rat. The procedure permitted identification of the highest dose which could be administered without causing compound related mortality) . The study was performed according to OECD guideline 401. Following a preliminary test, a group of ten animals (five male and five female) was given a single, oral dose of the test material at a dose level of 5000 mg/kg bodyweight. The animals were observed for 14 days after the day of dosing and were then killed for gross pathological examination. There were no deaths. Clinical signs of toxicity noted were piloerection, hunched posture, abnormal gait, lethargy, decreased respiratory rate, pallor of extremities, increased salivation, and diarrhoea; recovery was complete on day 5.
All animals showed expected gains in bodyweight over the study period. No abnormalities were noted at necropsy. The acute median lethal dose (LD50) of the test material was found to be greater than 5000 mg/kg bodyweight. The test material was considered not to have significant acute toxicity and does not require classification as harmful, toxic or very toxic according to the GHS scheme.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- The source substance (DTPA 5K) and the target substance (DTPA 3Na) are the pentapotassium and trisodium salts of the same organic acid (Diethylenetriaminepentaacetic acid) and are therefore structurally very similar. The two substances have comparable high water solubility and would be rapidly and fully dissociated into a common anion and sodium and potassium cations in the gastro-intestinal tract. The absorption, distribution and metabolism of the two substances would therefore be expected to be essentially identical. The common organic acid moiety has a chelating mode of action and would be expected to exert long-term, secondary adverse effects by the sequestration of essential metal ions, rather than specific acute organ toxicity. Sodium and potassium are normal physiological components of the body and are considered not to have any significant impact on the robustness of the read-across hypothesis.
- Reason / purpose for cross-reference:
- read-across source
- Specific details on test material used for the study:
- > 99% pure
- Species:
- rat
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Conclusions:
- The acute oral toxicty of DTPA trisodium salt is predicted to be in excess of 5,000 mg/Kg.bw.
- Executive summary:
The acute oral toxicity of DTPA pentapotassium salt is low with an LD50 value in excess of 5,000 mg/kg (OECD 401 guideline). DTPA pentapotassium salt is structurally similar to DTPA trisodium salt and the analogue has a similar chelating mode of action to the target substance. Based on a read-across approach DTPA trisodium salt is predicted to have similar low acute oral toxicity, with an LD50 in excess of 5,000 mg/kg.bw.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
- Justification for type of information:
- According to the specific rules for adaptation in column 2 of section 8.5 (Annex VIII), testing by a third acute route is not required if exposure to humans via inhalation is not likely. DTPN 3Na has a low vapour pressure (2.6 x 10-4 Pa at 25 °C.) and is imported and used as a 45-47% (w/w) solution in water (greater than 500 g/L). The potential for human exposure via the inhalation route is very limited.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No data on batch number and composition; basic data given; comparable to guidelines/standards (max. reliability score can be 2)
- Justification for type of information:
- The source substance (DTPA 5K) and the target substance (DTPA 3Na) are the pentapotassium and trisodium salts of the same organic acid and are therefore structurally very similar. The purity/impurity profile for the source material is not characterised in the acute dermal toxicity robust summary, but since the target material is > 99.9% pure and contains no detectable impurities, the extrapolation of acute dermal toxicological properties from the source material to the target material is considered valid as a ‘worst case' scenario. The source material acute dermall toxicity study was conducted according to OECD test guideline 402 and is considered reliable with restrictions (Category 2).
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- audited in-house
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Interfauna UK, Ltd., Huntingon, UK
- Age at study initiation: 7-10 weeks
- Weight at study initiation: 200-249 g
- Fasting period before study: no
- Housing: individually in metal cages with wire mesh floor
- Diet (e.g. ad libitum): ad lib
- Water (e.g. ad libitum): ad lib
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-22
- Humidity (%): 50 (mean)
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 13 To: 27 January 1987 - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: ca. 10% of total body surface
- % coverage: 10% of total body surface
- Type of wrap if used: gauze held in place with an impermeable dressing encircled around the trunk
REMOVAL OF TEST SUBSTANCE
- Washing (if done): warm water (30-40 degrees C)
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2.20 mL/kg bw
- Concentration (if solution): 90% w/v paste in distilled water
- Constant volume or concentration used: 2.20 mL/kg bw
- For solids, paste formed: yes
VEHICLE
- Amount(s) applied (volume or weight with unit): see above (2.20 mL/kg bw)
- Concentration (if solution): 90% w/v - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations twice daily, BW weekly.
- Necropsy of survivors performed: yes - Preliminary study:
- Not performed.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortality
- Clinical signs:
- other: No clinical signs of systemic reactions present.
- Gross pathology:
- No macroscopic changes noted.
- Other findings:
- Dermal responses:
The sites of application showed no general inflammatory responses, but 9 animals developed multiple minute encrustations on the
treated skin. These were first apparent on day 4 and resolved completely by day 9. - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute dermal LD50 is > 2000 mg/kg bw.
- Executive summary:
The study was performed to assess the acute toxicity of the test material following a single dermal administration to the Sprague-Dawley
strain rat. The procedure permitted identification of the LD50 value. The study was performed according to OECD guideline 402 and Method B3 of Commission Directive 92/69/EEC (which constitutes Annex V of Council Directive 67/548/EEC).
A group of ten animals (five male and five female) was given a single, dermal dose of the test material (lasting 24 hours) at a dose level of 2000 mg/kg bodyweight. The animals were observed for 14 days after the day of dosing and were then killed for gross pathological examination. There were no deaths. No clinical signs of systemic toxicity were noted. No inflammatory responses were noted, but 9/10 animals showed multiple minute encrustations on the treated skin on days 4 -9. Male animals showed expected gains in bodyweight over the study period, low body weight gains were noted in 4/5 females. No abnormalities were noted at necropsy.
The acute median lethal dose (LD50) of the test material was found to be greater than 2000 mg/kg bodyweight.
The test material was considered not to have significant acute toxicity and does not require classification as harmful, toxic or very toxic according to the EC scheme and GHS scheme.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- The source substance (DTPA 5K) and the target substance (DTPA 3Na) are the pentapotassium and trisodium salts of the same organic acid (Diethylenetriaminepentaacetic acid) and are therefore structurally very similar. The two substances have comparable high water solubility and would be dissociated into a common anion and sodium or potassium cations during dermal administration, with consequent low expected absorption. The common organic acid moiety has a chelating mode of action and would be expected to exert potential, long-term, secondary, adverse, systemic effects by the sequestration of essential metal ions, rather than specific acute organ toxicity. The neutral pH of the target substance would ameliorate any potential local dermal, irritant effects of the alkaline source substance
- Reason / purpose for cross-reference:
- read-across source
- Specific details on test material used for the study:
- > 99% purity
- Species:
- rat
- Type of coverage:
- occlusive
- Vehicle:
- water
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Limit test dosage
- Conclusions:
- The acute dermal toxicity of DTPA 3Na was predicted to be > 2,000 mg/kg. bw.
- Executive summary:
The acute dermal toxicity of DTPA pentapotassium salt is low with an LD50 valvue in excess of 2,000 mg/kg (OECD 402 test). DTPA pentapotassium salt is structurally similar to DTPA trisodium salt and the analogue has a similar chelating mode of action to the target substance. Based on a read-across approach DTPA trisodium salt is predicted to have similar low acute dermal,toxicity, with an LD50 in excess of 2,000 mg/kg.bw.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
The acute oral and dermal toxicities of DTPA pentapotassium salt are low, with LD50 values in excess of 5,000 mg/kg and 2,000 mg/kg, respectively (OECD 401 and 402 limit tests). DTPA pentapotassium salt is structurally similar to DTPA trisodium salt and the analogue has the same metal sequestering mode of action as the target substance. The counter ions are not considered to have any significant effect on the toxicities of the two substances. Based on a read-across approach, DTPA trisodium salt is predicted to have similarly low acute oral and dermal toxicity.
.
Justification for classification or non-classification
DTPA trisodium salt is considered not to meet the CLP criteria for classification for acute oral or dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.